A citation-based method for searching scientific literature

Xiaofeng Ding, Jingjing Cheng, Qingsong Pang, Xiaoying Wei, Ximei Zhang, Ping Wang, Zhiyong Yuan, Dong Qian. Int J Radiat Oncol Biol Phys 2019
Times Cited: 9







List of co-cited articles
24 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate.
Emanuelle Pascolo, Christian Wenz, Joachim Lingner, Norbert Hauel, Henning Priepke, Iris Kauffmann, Pilar Garin-Chesa, Wolfgang J Rettig, Klaus Damm, Andreas Schnapp. J Biol Chem 2002
187
33


Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells.
Davood Bashash, Seyed H Ghaffari, Rooholah Mirzaee, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Leuk Lymphoma 2013
21
22

Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription.
D Bashash, S H Ghaffari, F Zaker, K Hezave, M Kazerani, A Ghavamzadeh, K Alimoghaddam, S A Mosavi, A Gharehbaghian, P Vossough. Cancer Invest 2012
21
22

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.
Muhammad Khairul Ramlee, Jing Wang, Wei Xun Toh, Shang Li. Genes (Basel) 2016
70
22

Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells.
Andrea Celeghin, Silvia Giunco, Riccardo Freguja, Manuela Zangrossi, Silvia Nalio, Riccardo Dolcetti, Anita De Rossi. Cell Death Dis 2016
19
22

Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
Davood Bashash, Mohadeseh Zareii, Ava Safaroghli-Azar, Mir Davood Omrani, Seyed H Ghaffari. Hematology 2017
13
22

Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells.
Weimin Kong, Nenan Lv, Weiya Z Wysham, Dario R Roque, Tongqing Zhang, Simeng Jiao, Dan Song, Jiao Chen, Victoria L Bae-Jump, Chunxiao Zhou. J Cancer 2015
19
22


Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
Xiao-Qin Wu, Cheng Huang, Xu He, Yuan-Yao Tian, De-Xi Zhou, Yong He, Xin-Hua Liu, Jun Li. Cell Signal 2013
37
22

RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells.
Rajika Arora, Yongwoo Lee, Harry Wischnewski, Catherine M Brun, Tobias Schwarz, Claus M Azzalin. Nat Commun 2014
196
22

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
Paal F Brunsvig, Steinar Aamdal, Marianne K Gjertsen, Gunnar Kvalheim, Carrie J Markowski-Grimsrud, Ingunn Sve, Marianne Dyrhaug, Sissel Trachsel, Mona Møller, Jon A Eriksen,[...]. Cancer Immunol Immunother 2006
161
22

Cancer. Cancer and telomeres--an ALTernative to telomerase.
Jerry W Shay, Roger R Reddel, Woodring E Wright. Science 2012
82
22

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.
Ricardo Leão, Joana Dias Apolónio, Donghyun Lee, Arnaldo Figueiredo, Uri Tabori, Pedro Castelo-Branco. J Biomed Sci 2018
74
22

Novel anticancer therapeutics targeting telomerase.
Maria Ruden, Neelu Puri. Cancer Treat Rev 2013
188
22

TERT promoter mutations in telomere biology.
Barbara Heidenreich, Rajiv Kumar. Mutat Res Rev Mutat Res 2017
76
22

Frequent amplification of the telomerase reverse transcriptase gene in human tumors.
A Zhang, C Zheng, C Lindvall, M Hou, J Ekedahl, R Lewensohn, Z Yan, X Yang, M Henriksson, E Blennow,[...]. Cancer Res 2000
115
22

Telomerase activity in non-small cell lung cancer.
Katarzyna Dobija-Kubica, Marzena Zalewska-Ziob, Krzysztof Bruliński, Paweł Rogoziński, Andrzej Wiczkowski, Agata Gawrychowska, Jacek Gawrychowski. Kardiochir Torakochirurgia Pol 2016
4
50

Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Weiran Liu, Yuesong Yin, Jun Wang, Bowen Shi, Lianmin Zhang, Dong Qian, Chenguang Li, Hua Zhang, Shengguang Wang, Jinfang Zhu,[...]. Oncotarget 2017
16
22

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.
A A Chiappori, T Kolevska, D R Spigel, S Hager, M Rarick, S Gadgeel, N Blais, J Von Pawel, L Hart, M Reck,[...]. Ann Oncol 2015
85
22





Receptor‑interacting serine/threonine‑protein kinase 1 promotes the progress and lymph metastasis of gallbladder cancer.
Guangwei Zhu, Qiang Du, Xiao Chen, Xiaoqian Wang, Nanhong Tang, Feifei She, Yanling Chen. Oncol Rep 2019
2
50

Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.
I Bièche, C Noguès, V Paradis, M Olivi, P Bedossa, R Lidereau, M Vidaud. Clin Cancer Res 2000
169
11

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition.
M Hinz, D Krappmann, A Eichten, A Heder, C Scheidereit, M Strauss. Mol Cell Biol 1999
645
11



Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-I Tax.
R Iwanaga, E Ozono, J Fujisawa, M A Ikeda, N Okamura, Y Huang, K Ohtani. Oncogene 2008
45
11

hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression.
K L Kirkpatrick, W Ogunkolade, A E Elkak, S Bustin, P Jenkins, M Ghilchick, R F Newbold, K Mokbel. Breast Cancer Res Treat 2003
44
11

Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action.
Susanne C Miller, Ruili Huang, Srilatha Sakamuru, Sunita J Shukla, Matias S Attene-Ramos, Paul Shinn, Danielle Van Leer, William Leister, Christopher P Austin, Menghang Xia. Biochem Pharmacol 2010
141
11

Demethylation and alterations in the expression level of the cell cycle-related genes as possible mechanisms in arsenic trioxide-induced cell cycle arrest in human breast cancer cells.
Farima Moghaddaskho, Haniyeh Eyvani, Mohsen Ghadami, Javad Tavakkoly-Bazzaz, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Seyed H Ghaffari. Tumour Biol 2017
12
11

Telomerase directly regulates NF-κB-dependent transcription.
Arkasubhra Ghosh, Gaye Saginc, Shi Chi Leow, Ekta Khattar, Eun Myong Shin, Ting Dong Yan, Marc Wong, Zhizhuo Zhang, Guoliang Li, Wing-Kin Sung,[...]. Nat Cell Biol 2012
208
11

Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism.
Seyed H Ghaffari, Meysam Yousefi, Majid Zaki Dizaji, Majid Momeny, Davood Bashash, Ali Zekri, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Asian Pac J Cancer Prev 2016
15
11

Arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells through activation of caspase-3 and inhibition of HERG channels.
Ying Wang, Yong Zhang, Lei Yang, Benzhi Cai, Jianping Li, You Zhou, Li Yin, Lili Yang, Bao Feng Yang, Yan Jie Lu. Exp Ther Med 2011
25
11

Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells.
Majid Momeny, Hassan Yousefi, Haniyeh Eyvani, Farima Moghaddaskho, Ali Salehi, Fatemeh Esmaeili, Zivar Alishahi, Farinaz Barghi, Somaye Vaezijoze, Sahar Shamsaiegahkani,[...]. Int J Biochem Cell Biol 2018
16
11


Enterolactone Induces G1-phase Cell Cycle Arrest in Nonsmall Cell Lung Cancer Cells by Downregulating Cyclins and Cyclin-dependent Kinases.
Shireen Chikara, Kaitlin Lindsey, Harsharan Dhillon, Sujan Mamidi, Jeffrey Kittilson, Melpo Christofidou-Solomidou, Katie M Reindl. Nutr Cancer 2017
21
11

Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription.
Seyed H Ghaffari, Majid Momeny, Davood Bashash, Roohollah Mirzaei, Ardeshir Ghavamzadeh, Kamran Alimoghaddam. Hematology 2012
33
11

Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells.
C Lavanya, Manjunatha M Venkataswamy, M K Sibin, M M Srinivas Bharath, G K Chetan. Cytotechnology 2018
11
11


Arsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.
Seong-Su Han, Kihyun Kim, Eun-Ryeong Hahm, Chan H Park, Bruce F Kimler, Sook J Lee, Se-Hoon Lee, Won S Kim, Chul Won Jung, Keunchil Park,[...]. J Cell Biochem 2005
41
11


Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex.
Hai-Yang Wang, Biao Zhang, Jun-Nian Zhou, Dong-Xing Wang, Ying-Chen Xu, Quan Zeng, Ya-Li Jia, Jia-Fei Xi, Xue Nan, Li-Juan He,[...]. Cell Death Dis 2019
22
11

NF-κB, an active player in human cancers.
Yifeng Xia, Shen Shen, Inder M Verma. Cancer Immunol Res 2014
490
11



Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer.
Elaheh Nooshinfar, Davood Bashash, Ava Safaroghli-Azar, Samaneh Bayati, Mostafa Rezaei-Tavirani, Seyed H Ghaffari, Mohammad Esmaeil Akbari. Biomed Pharmacother 2016
32
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.